Cell therapy for Parkinson's disease: Why it doesn't work every time-Reference-Cited by-同舟云学术

Cell therapy for Parkinson's disease: Why it doesn't work every time

Published:2019-06-24 Issue:8 Volume:34 Page:1120-1127
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Collier Timothy J.¹,Sortwell Caryl E.¹,Mercado Natosha M.¹,Steece‐Collier Kathy¹

Affiliation:

1. Translational Science and Molecular Medicine, Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA, and Hauenstein Neuroscience CenterMercy Health/St. Mary's Grand Rapids Michigan USA

Funder

National Institutes of Health

Parkinson's Disease Foundation

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27742

Reference40 articles.

1. Cell-based therapies for Parkinson disease—past insights and future potential

2. Developing dopaminergic cell therapy for Parkinson's disease-give up or move forward?

3. Neural grafting for Parkinson's disease: challenges and prospects

4. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants

5. Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine System

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing age and the rs6265 BDNF SNP are permissive to graft-induced dyskinesias in parkinsonian rats;npj Parkinson's Disease;2024-08-23

2. Combining physical & cognitive training with iPSC-derived dopaminergic neuron transplantation promotes graft integration & better functional outcome in parkinsonian marmosets;Experimental Neurology;2024-04

3. Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson’s disease;Molecular Biology Reports;2024-02-24

4. Downregulation of striatal CaV1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age;Neurobiology of Disease;2023-06

5. Gene Therapy for Alzheimer and Parkinson Diseases;Current Gene Therapy;2023-06